Long-Term Management of Overactive Bladder with Antimuscarinic Agents-Reference-Cited by-同舟云学术

Long-Term Management of Overactive Bladder with Antimuscarinic Agents

Published:2007-03 Issue:5 Volume:6 Page:432-437
ISSN:1569-9056
Container-title:European Urology Supplements
language:en
Short-container-title:European Urology Supplements

Author:

Hampel Christian

Publisher

Elsevier BV

Subject

Urology

Reference20 articles.

1. Recommendations of the International Scientific Committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse and faecal incontinence;Abrams,2005

2. Medium-term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder compliance;Kelleher;Br J Obstet Gynaecol,1997

3. Immediate-release oxybutynin versus tolterodine in detrusor overactivity: a population analysis;Lawrence;Pharmacotherapy,2000

4. Utilization patterns associated with tolterodine IR vs. oxybutinin in the management of urinary incontinence;Boccuzzi;Value Health,2002

5. Prevalence and burden of overactive bladder in the United States;Stewart;World J Urol,2003

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long‐term real‐life adherence of percutaneous tibial nerve stimulation in over 400 patients;Neurourology and Urodynamics;2019-12-17

2. Phase III Study to Assess Long-Term (52-Week) Safety and Efficacy of Mirabegron, a β3-Adrenoceptor Agonist, in Japanese Patients with Overactive Bladder;LUTS: Lower Urinary Tract Symptoms;2015-07-07

3. Refractory overactive bladder: a common problem?;International Urogynecology Journal;2015-03-20

4. Medication adherence in the management of nocturia: challenges and solutions;Patient Preference and Adherence;2015-01

5. Efficacy and Safety of the Selective β3 -Adrenoceptor Agonist Mirabegron in Japanese Patients with Overactive Bladder: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study;LUTS: Lower Urinary Tract Symptoms;2014-03-11